RXO, Inc.: Valuation Appears To Have Priced In All The Positives
RXO remains a hold as Q1 earnings were weak, but contract rates and spot mix are improving. Contract repricing and higher spot freight volumes are beginning to support sequential margin recovery, with Q2 EBITDA guidance sharply higher at $27–37 million. Valuation already prices in significant recovery; normalized EPS expectations require sustained volume and earnings growth beyond current levels.
RXO - RXO, Inc.